Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by MrMugsyon May 28, 2021 2:02pm
142 Views
Post# 33287297

RE:Hello Bag Holders

RE:Hello Bag Holders
Duster340 wrote: another month has come and gone, only 4 more months of dead money to go hang in there lol. . i have built up a nice nest egg ready to deploy here in september prior to the run-up  in stock price. in the mean time i sugest to avoid investing in ate and invest in stocks that are on the move such as in the energy sector and also i have put some cash into some of the beat up pot stocks that operate in the usa. i think they will do very good moving forward. catalyst coming next year for them.
glta


Not sure why you would specifically tell investors to "avoid" investing in ATE considering that I am an accumulator.  You have me scratching my head as I make purchases.

: )

Wouldn't you feel bad if you were wrong with your prediction and the stock jumped before the fall.  Others would point to this comment on the daily ... everytime you tried to post something.

Remember ... from Feb 5 to Feb 17, this stock jumped to $7.  It wouldn't take much news to do it again.  IMO.

Just trying to help you save face if you get it way-wrong. 
Too much confidence in that post - I'd say.


<< Previous
Bullboard Posts
Next >>